within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07C_BacterialAndViralVaccinesCombined.J07CA07_DiphtheriaHepatitisBTeta;

model DiphtheriaHepatitisBTeta
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 0,
    adminDuration = 600,
    adminMass = 0.5 / 1000000,
    adminCount = 1,
    Vd = 0.001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>DiphtheriaHepatitisBTetanus</td></tr><tr><td>ATC code:</td><td>J07CA07</td></tr><td>route:</td><td>intramuscular</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0</td><td></td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>A combination vaccine used to provide immunization against diphtheria, hepatitis B, and tetanus. This vaccine is primarily employed in routine pediatric immunization schedules and is approved in many countries for that purpose.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data available for the combination vaccine in any population, as vaccines of this type (containing inactivated bacterial toxins and recombinant viral proteins, administered intramuscularly) are generally not subject to classic pharmacokinetic analysis involving absorption, distribution, metabolism, and excretion.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J07CA07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end DiphtheriaHepatitisBTeta;
